Related Experiment Video
Updated: Mar 7, 2026
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.8K
Dyslipidemia in systemic lupus erythematosus
Melinda Zsuzsanna Szabó1, Peter Szodoray2, Emese Kiss3,4
1Department of Clinical Immunology, Adult and Pediatric Rheumatology, National Institute of Rheumatology and Physiotherapy, Budapest, Hungary. szabo.melinda@orfi.hu.
Immunologic Research
|February 8, 2017
Summary
Dyslipidemia is common in systemic lupus erythematosus (SLE), affecting 60% of patients within three years and increasing cardiovascular disease risk. Aggressive lipid management is crucial to prevent atherosclerosis in SLE patients.
Area of Science:
- Rheumatology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease (CVD) is a leading cause of death in systemic lupus erythematosus (SLE) patients.
- Accelerated atherosclerosis in SLE stems from traditional and non-traditional risk factors.
- Traditional factors like hypertension and hypercholesterolemia are significant contributors to premature atherosclerosis in SLE.
Purpose of the Study:
- To summarize the epidemiology of dyslipidemia in SLE patients.
- To review the pathogenesis of lipid abnormalities in SLE.
- To highlight the importance of aggressive dyslipidemia management for CVD risk reduction.
Main Methods:
- Review of epidemiological data on dyslipidemia in SLE.
- Analysis of current research on the pathogenesis of lipid abnormalities in SLE.
- Evaluation of the role of traditional and non-traditional risk factors.
Main Results:
- Dyslipidemia prevalence rises from 30% at SLE diagnosis to 60% within three years.
- Elevated total cholesterol, LDL, triglycerides, and ApoB, with reduced HDL, are common.
- Pathogenic mechanisms include inflammation (CRP, ESR), autoantibodies, reduced LPL activity, and oxidative stress.
Conclusions:
- Dyslipidemia is a major risk factor for atherosclerosis and CVD in SLE.
- Aggressive treatment of dyslipidemia is essential to mitigate cardiovascular risk.
- Statins may offer benefits beyond lipid reduction by inhibiting immune activation and reducing lupus activity.
Related Concept Videos
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
722
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
722
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:18Lipids: Dietary Sources and Requirements
2.4K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.4K
01:26Atherosclerosis III: Management
540
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
540
01:30Atherosclerosis I: Introduction
1.7K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.7K
01:24Nephrotic Syndrome I : Introduction
789
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
789